| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERATE DIAGNOSTICS INC | 4,778,049 | 104,209,249 | 11.90% | ||
| 2 | QUIDEL CORP COM | 3,256,957 | 88,914,926 | 10.16% | ||
| 3 | TENET HEALTHCARE CORP | 1,755,950 | 75,172,219 | 8.59% | ||
| 4 | ACORDA THERAPEUTICS | 1,956,414 | 74,167,655 | 8.47% | ||
| 5 | MAZOR ROBOTICS LTD | 3,194,562 | 65,296,847 | 7.46% | ||
| 6 | THORATEC LABS CORP | 1,756,204 | 62,889,665 | 7.18% | ||
| 7 | OPKO HEALTH INC | 5,571,960 | 51,930,667 | 5.93% | ||
| 8 | HANSEN MEDICAL INC | 19,658,147 | 51,111,182 | 5.84% | ||
| 9 | NXSTAGE MED INC COM | 3,599,192 | 45,853,706 | 5.24% | ||
| 10 | TRANSITION THERAPEUTICS INC | 4,287,412 | 34,170,674 | 3.90% | ||
| 11 | ACCURAY INCORPORATED COM | 3,240,006 | 31,104,058 | 3.55% | ||
| 12 | IRONWOOD PHARMACEUTICALS INC COM CL A | 1,846,005 | 22,742,782 | 2.60% | ||
| 13 | REPROS THERAPEUTICS INC | 1,242,326 | 22,038,863 | 2.52% | ||
| 14 | VERMILLION INC | 7,139,960 | 21,062,882 | 2.41% | ||
| 15 | TESARO INC | 633,752 | 18,683,009 | 2.13% | ||
| 16 | ENDOCYTE INC | 670,000 | 15,952,700 | 1.82% | ||
| 17 | BIOLASE INC | 6,135,910 | 14,787,543 | 1.69% | ||
| 18 | INTREXON CORP | 550,000 | 14,459,500 | 1.65% | ||
| 19 | PACIFIC BIOSCIENCES CALIF IN | 2,575,729 | 13,780,150 | 1.57% | ||
| 20 | WebMD Health Corp | 300,141 | 12,425,837 | 1.42% | ||
| 21 | GENTIVA HEALTH SER | 847,600 | 7,730,112 | 0.88% | ||
| 22 | DERMA SCIENCES INC COM PAR .01 | 500,000 | 6,340,000 | 0.72% | ||
| 23 | AMARIN CORP PLC | 3,000,000 | 5,430,000 | 0.62% | ||
| 24 | AGENUS INC | 1,375,634 | 4,360,763 | 0.50% | ||
| 25 | AGIOS PHARMACEUTICALS INC | 100,000 | 3,915,000 | 0.45% | ||
| 26 | BIOGEN INC | 11,530 | 3,526,681 | 0.40% | ||
| 27 | METABOLIX INC RESTRICTED | 1,658,126 | 2,155,564 | 0.25% | ||
| 28 | GTX INC | 497,769 | 761,587 | 0.09% | ||
| 29 | LADENBURG THALMAN FIN SVCS I | 166,849 | 503,884 | 0.06% | ||
| 30 | GILEAD SCIENCES INC | 50,000 | 99,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-14-001204, filed 2014.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
